Acumen Pharmaceuticals Debt-to-Assets Ratio Growth & History (ABOS)
Acumen Pharmaceuticals's debt-to-assets ratio was 0.25 for fiscal 2025.
View full Acumen Pharmaceuticals company overviewAcumen Pharmaceuticals annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.25 | 0.13 | +105.11% |
| 2024 | 2024-12-31 | 0.12 | 0.02 | +24.14% |
| 2023 | 2023-12-31 | 0.10 | 0.10 | +18643.40% |
| 2022 | 2022-12-31 | 0.00 | 0.00 | — |
| 2021 | 2021-12-31 | 0.00 | — | — |
Acumen Pharmaceuticals quarterly debt-to-assets ratio
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.27 | 0.10 | +55.78% |
| Q1 2026 | 2026-03-31 | 0.23 | 0.09 | +60.12% |
| Q4 2025 | 2025-12-31 | 0.25 | 0.13 | +105.11% |
| Q3 2025 | 2025-09-30 | 0.22 | 0.10 | +93.03% |
| Q2 2025 | 2025-06-30 | 0.18 | 0.07 | +70.21% |
| Q1 2025 | 2025-03-31 | 0.15 | 0.04 | +43.33% |
| Q4 2024 | 2024-12-31 | 0.12 | 0.02 | +24.14% |
| Q3 2024 | 2024-09-30 | 0.11 | 0.11 | +1608232.91% |
| Q2 2024 | 2024-06-30 | 0.10 | 0.10 | +62837.29% |
| Q1 2024 | 2024-03-31 | 0.10 | 0.10 | +28391.53% |
| Q4 2023 | 2023-12-31 | 0.10 | 0.10 | +18643.40% |
| Q3 2023 | 2023-09-30 | 0.00 | −0.00 | −98.93% |
| Q2 2023 | 2023-06-30 | 0.00 | −0.00 | −79.28% |
| Q1 2023 | 2023-03-31 | 0.00 | −0.00 | −60.95% |
| Q4 2022 | 2022-12-31 | 0.00 | 0.00 | — |
| Q3 2022 | 2022-09-30 | 0.00 | — | — |
| Q2 2022 | 2022-06-30 | 0.00 | — | — |
| Q1 2022 | 2022-03-31 | 0.00 | — | — |
| Q4 2021 | 2021-12-31 | 0.00 | — | — |
Acumen Pharmaceuticals debt-to-assets ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Acumen Pharmaceuticals's debt-to-assets ratio increased from 0.00 to 0.25, a change of 0.25. The latest reported quarter, Q2 2026, shows 0.27.
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acumen Pharmaceuticals source filings ↗Community posts
Acumen’s cash falls as November Alzheimer’s trial results approach
Acumen ($ABOS) reported $78.6 million of cash, equivalents and marketable securities at the end of its third quarter of 2026, down from $110.2 million three months earlier. Management expects those resources to fund current clinical and ope ...